Pharvaris share price logo

Pharvaris

NASDAQ: PHVS

Mid Cap

$36.23

-0.16

(-0.44%)

as on

Pharvaris Stock Performance

as on August 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $36.12
    $36.93
    downward going graph

    0.30%

    Downside

    1.93%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $20.65
    $36.93
    downward going graph

    43.00%

    Downside

    1.93%

    Upside

    downward going graph

Pharvaris share price movements today

Previous Close
$36.39
Open
$36.68
Volume
585.1K
Market Cap
$2.5B
Day's Low - High
$36.12 - $36.93
52 Week Low - High
$20.65 - $36.93

Pharvaris Historical Returns

1 Month Return
+ 0.57 %
3 Month Return
+ 15.59 %
1 Year Return
+ 57.58 %
3 Year Return
+ 81.88 %
5 Year Return
+ 110.42 %

Pharvaris Stock Fundamentals & Key Indicators

Check Pharvaris market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.5B

EPS (TTM)

-2.83

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.84

Industry PE ratio

-13.046547619047619

PEG Ratio

-0.8961797909322481

EBITDA

-166.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-61.24%

Pharvaris Stock Valuation

Track how Pharvaris P/E has moved over time to understand its valuation trends.

Pharvaris in the last 5 years

  • Overview

  • Trends

Lowest (-9.66x)

March 31, 2024

Industry (-13.05x)

March 31, 2026

Today (-7.95x)

March 31, 2026

Highest (-4.62x)

March 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -7.95x

Pharvaris vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharvaris with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$2.5B110.42%-10.840.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Pharvaris Stock including INR - Dollar returns

The Pharvaris stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pharvaris investment value today

Current value as on today

₹1,78,084

Returns

₹78,084

(+78.08%)

Returns from Pharvaris Stock

₹62,466 (+62.47%)

Dollar Impact

₹15,618 (+15.62%)

Analyst Recommendation on Pharvaris Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.88888888888889% of analysts recommend a 'BUY' rating for Pharvaris. Average target price of $48.68

Pharvaris Share Price Target

Get share price movements and forecasts by analysts on Pharvaris.

What analysts predicted

25.58%UPSIDE

Target Price

$48.68

Current Price

$36.23

Analyzed by

9 Analysts

Target

$48.68

Pharvaris target price $48.68, a slight upside of 25.58% compared to current price of $36.23. According to 9 analysts rating.

Indian Investors' Interest in Pharvaris Stock

Search interest for Pharvaris Stock has increased by 337% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:337% versus previous 30 day period

Pharvaris Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
-
-
0
Operating Income
-22
-24
-26
-28
-34
-37
42
-40
-39
-45
EBITDA
-24
-23
-26
-27
-29
-41
-42
-45
-37
-39
Interest Expense
-
0
-
-
-
0
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-24
-23
-23
-27
-29
-41
-46
-45
-37
-39
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-24
-23
-23
-28
-29
-41
-46
-45
-37
-39
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pharvaris Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Mar 2021
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
Operating Income
-4
-8
-28
-54
-86
-96
-145
-169
EBITDA
-4
-8
-29
-42
-86
-99
-145
-173
Interest Expense
-
-
0
0
0
-
-
-
Depreciation
4
-
-
0
0
0
0
0
Income Before Tax
-4
-8
-29
-42
-75
-99
-132
-173
Income Tax Expense
0
-
0
0
0
1
1
1
Net Income
-4
-8
-29
-42
-76
-100
-134
-175
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pharvaris Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Net Income
-22
-21
-23
-27
-29
-41
-46
-45
-37
-39
Operating Cash Flow
-25
-20
-23
-24
-27
-33
-38
-29
-30
-49
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
63
0
0
0
0
0
0
160
0
Change in Cash
-26
44
-20
-22
-24
-38
-44
-36
129
-50

Pharvaris Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Mar 2021
Dec 2021
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
-4
-8
-26
-42
-75
-99
-132
-173
Operating Cash Flow
-3
-6
-21
-44
-67
-93
-120
-137
Investing Cash Flow
-
0
0
0
0
0
0
0
Financing Cash Flow
4
21
101
143
8
325
2
160
Change in Cash
0
14
78
110
-47
229
-110
10

Mutual Funds that own Pharvaris Stock

Check out the Mutual Funds with significant holdings in Pharvaris.

Funds
Holdings
Shares Held
Fidelity Mt. Vernon Street Trust
2.841649%
1985281
Fidelity Securities Fund
1.389773%
970947
Fidelity Select Portfolios
1.356805%
947914
Fidelity Advisor Series VII
0.715679%
500000
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
0.474536%
331529

Global Institutional Holdings in Pharvaris

Funds
Holdings
Andreas Halvorsen
5.23%
James E. Flynn
4.47%
iShares
0.9%
Felix Baker
0.54%
Michael Rockefeller
0.14%

Pharvaris News & Key Events

  • img

    Today's Timeline - 15 July

    Wed, 06:06 PM

    -

    Wells Fargo initiates coverage on Pharvaris with an overweight rating and a $55 price target.

    Wed, 09:30 PM

    -

    Pharvaris shows strong momentum with a Zacks Rank of #2 and significant share price increases over various timeframes.

Insights on Pharvaris

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PHVS stock has moved up by 3.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 480.4% return, outperforming this stock by 424.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 608.9% return, outperforming this stock by 526.9%

About Pharvaris

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
OrganisationPharvaris
HeadquartersGrafenauweg 8, Zug, Switzerland, 6300
IndustryBiotechnology
CEOMr. Berndt Axel Edvard Modig CPA, M.B.A.
E-voting on sharesClick here to vote

Key Management of Pharvaris

Name

Title

Dr. Anne A. Lesage Ph.D.

Chief Early Development Officer

Mr. Wim Souverijns Ph.D.

Chief Commercial Officer

Ms. Anna Nijdam M.Sc., R.A.

Head of Strategic Finance & Principal Accounting Officer

Dr. Stefan Abele Ph.D.

Chief Technology Operations Officer

Ms. Annick Deschoolmeester

Chief Human Resources Officer

Maryann Cimino

Director of Corporate Relations

Mr. Berndt Axel Edvard Modig CPA, M.B.A.

Co-Founder, CEO & Executive Director

Dr. Peng Lu M.D., Ph.D.

President

Mr. David W. Nassif J.D.

CFO, Chief Legal Officer & Corporate Secretary

FAQs

What is Pharvaris share price today?

Pharvaris share price today is $36.23 as on at the close of the market. Pharvaris share today touched a day high of $36.93 and a low of $36.12.

What is the 52 week high and 52 week low for Pharvaris share?

Pharvaris share touched a 52 week high of $36.93 on and a 52 week low of $20.65 on . Pharvaris stock price today i.e. is closed at $36.23,which is 1.90% down from its 52 week high and 75.45% up from its 52 week low.

What is Pharvaris's market capitalisation today?

Pharvaris market capitalisation is $0.00T as on .

How to invest in Pharvaris Stock (PHVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharvaris on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharvaris Shares that will get you 0.0414 shares as per Pharvaris share price of $36.23 per share as on August 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Pharvaris Stock (PHVS) from India?

Indian investors can start investing in Pharvaris (PHVS) shares with as little as ₹95.685 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.85 in Pharvaris stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharvaris share’s latest price of $36.23 as on August 22, 2026 at 1:29 am IST, you will get 0.2760 shares of Pharvaris. Learn more about fractional shares .

What are the returns that Pharvaris has given to Indian investors in the last 5 years?

Pharvaris stock has given 110.42% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?